GAME CHANGER!! Zydus Unveils ANVIMO - A Revolutionary Drug for Transplant Patients Business Zydus Lifesciences has introduced a groundbreaking medication, ANVIMO, designed to prevent infections in patients undergoing bone marrow transplants and kidney transplants.
PRIORITISE DIGITAL EQUITY!! Smriti Irani Calls for Equity in Technology to Achieve Gender Parity Business
MAKE IN USA!! Trump Secures $100 Billion TSMC Investment to Bolster U.S. Chip Manufacturing International